S. Dzik

发表

Early goal-directed therapy in the treatment of severe sepsis and septic shock

S. Dzik, 2002 .

Qualitätsmanagement · Quality Management

S. Dzik, 1999 .

The immunological synapse: A molecular machine controlling T cell activation

S. Dzik, Sunny Dzik, 2000 .

The use of albumin and/or colloids in newborns: A meta-analysis

S. Dzik, 2002 .

Characterization of CMV pp65-specific CD8+ T lymphocytes using MHC tetramers in kidney transplant patients and healthy participants

S. Dzik, 2001 .

Universal WBC reduction

P. Mintz, S. Kleinman, M. Kanter, 2000, Transfusion.

Leukocyte reduction of blood components: public policy and new technology.

S. Kleinman, M. Murphy, C. Manno, 2000, Transfusion medicine reviews.

Is fresh frozen plasma overtransfused in the United States?

S. Dzik, J. Wallis, 2004, Transfusion.

NON-INFECTIOUS SERIOUS HAZARDS OF TRANSFUSION

S. Dzik, 2003 .

COVID‐19 and ABO blood groups

S. Dzik, R. Kaufman, C. North, 2020, Transfusion.

Apoptosis, transforming growth factor‐β, and the immunosuppressive effect of transfusion

S. Dzik, F. Puppo, M. Mincheff, 2002, Transfusion.

A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease

J. Freedman, M. Reid, S. Dzik, 1996 .

Supplemental perioperative oxygen to reduce the incidence of surgical wound infection

S. Dzik, 2000 .

Clinical and molecular basis of transfusion-induced immunomodulation: summary of the proceedings of a state-of-the-art conference.

S. Dzik, E. Vamvakas, M. Blajchman, 2001, Transfusion medicine reviews.

Lysophosphatidic acid opens a Ca++ channel in human erythrocytesL. Yang, D. A. Andrews, P.S. Low. Blood 95:2420–2425, 2000

S. Dzik, 2000 .

CD34+ cell selection from frozen cord blood products using the Isolex 300i and CliniMACS CD34 selection devicesMcNiece IK, Stoney GB, Kern BP, et al. J Hematother 7:457–461, 1998

S. Dzik, 1999 .

Blood stored for 42 days delivers oxygen as well as blood stored for 7 days

S. Dzik, 2021, Transfusion.

Nitric oxide: Nature's third respiratory gas

S. Dzik, 2002, Transfusion.

A touch of TRALI

S. Dzik, C. Stowell, R. Makar, 2008, Transfusion.

Complement and Coagulation: Cross Talk Through Time.

S. Dzik, 2019, Transfusion medicine reviews.

Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopenia

S. Dzik, 2001 .

Is iron gluconate really safer than iron dextran?

S. Foran, S. Dzik, Q. Eichbaum, 2003, Blood.

HLA Antigens on Leukocyte Fragments and Plasma Proteins: Prestorage Leukoreduction by Filtration

S. Dzik, P. Szuflad, S. Eaves, 1994, Vox sanguinis.

Aprotinin and transfusion requirements in orthotopic liver transplantation: A multicenter randomized double-blind studyR.J. Porte, I.Q. Molenaar, B. Begliomini, et al. Lancet 355:1303–1309, 2000

S. Dzik, 2000 .

Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: A randomized controlled trial

S. Dzik, 2000 .

COVID-19 Convalescent Plasma: Now Is the Time for Better Science

S. Dzik, 2020, Transfusion Medicine Reviews.

Transfusion requirements in critical care: A multicentre randomized controlled clinical trialHebert PC, Wells G, Blajchman MA, et al. N Engl J Med 340:409–417, 1999

S. Dzik, 1999 .

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin 10 secretion

S. Dzik, 2000 .

Hyperhemolysis syndrome in anemia of chronic disease

S. Dzik, K. Darabi, 2005, Transfusion.

Leukodepletion blood filters: filter design and mechanisms of leukocyte removal.

S. Dzik, 1993, Transfusion medicine reviews.

Mechanisms of leukocyte removal by filtration.

S. Dzik, 1994, Current studies in hematology and blood transfusion.

International Survey of Trials of Convalescent Plasma to Treat COVID-19 Infection

L. Estcourt, S. Dzik, J. Grant-Casey, 2020, Transfusion Medicine Reviews.

The effect of overnight storage of leukapheresis stem cell products on cell viability, recovery, and costSugrue MW, Hutcheson CE, Fisk DD, et al. J Hematother 7:431–436, 1998

S. Dzik, 1999 .

Monoclonal Antibody-mediated inhibition of the human HLA alloimmune response to platelet transfusion is antigen specific and independent of Fcγ receptor-mediated immune suppression

S. Dzik, 2001 .

How I do it: platelet support for refractory patients

S. Dzik, 2007, Transfusion.

A multicenter study evaluating three methods for counting residual WBCs in WBC‐reduced blood components: Nageotte hemocytometry, flow cytometry, and microfluorometry

S. Dzik, G. Moroff, L. Dumont, 2000, Transfusion.

Principles of counting low numbers of leukocytes in leukoreduced blood components.

S. Dzik, 1997, Transfusion medicine reviews.

Therapeutic plasma exchange: An update from the Canadian apheresis group

S. Dzik, 2000 .

Prestorage leukocyte reduction of cellular blood components.

S. Dzik, 1994, Transfusion science.

The nature of the principal type 1 interferon-producing cells in human blood

S. Dzik, 2000 .

Determination of RhD Zygosity: Comparison of a double amplification refractory mutation system approach and a multiplex real-time quantitative PCR approach

S. Dzik, 2001 .

Artificial Intelligence and Scholarship in the 21st Century.

S. Dzik, Rachel Garland, M. Murphy, 2023, Transfusion medicine reviews.

Leukocyte-depletion of blood components does not significantly reduce the risk of infectious complications: Results of a double-blinded, randomized studyI.L. Titlestad, L.S. Ebbesen, A.P. Ainsworth, et al. Int J Colorectal Dis 16:147–153, 2001

S. Dzik, 2002 .

Role of CD47 as a marker of self on red blood cells: P.A. Oldenborg, A. Zheleznyak, Y.F. Fang, et al. Science 288:2051–2054, 2000

S. Dzik, 2001 .

James Blundell, Obstetrical Hemorrhage, and the Origins of Transfusion Medicine.

S. Dzik, 2018, Transfusion medicine reviews.

Leukoreduction: Current State of the Art

S. Dzik, 1998, Transfusion Medicine and Hemotherapy.

Simple trick to improve blood flow during apheresis

S. Dzik, Jefhey Kane, 1998, Transfusion.

Lack of clinically significant contact system activation during platelet concentrate filtration by leukocyte removal filters

S. Dzik, 1999 .

COVID-19, plasma, and hypogammaglobulinemia

M. Murphy, S. Dzik, 2020, Blood.

Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppressionZ.-X. Zhang, L. Yang, K.J. Young, et al. Nature 6:782–789, 2000

S. Dzik, 2001 .

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpuraTsai HM, Lian EC. N Engl J Med 339:1585–1594, 1998

S. Dzik, 1999 .

Immunochemical analysis of the Kx protein from human red cells of different kell phenotypes using antibodies raised against synthetic peptides

J. Freedman, M. Reid, S. Dzik, 1997 .

S. Dzik, Michael Murphy, 2021, Transfusion Medicine Reviews.

Epitope mapping: three‐dimensional insights from molecular biology

S. Dzik, 1999, Transfusion.

Current Research on the Immunomodulatory Effect of Allogeneic Blood Transfusion

S. Dzik, M. Blajchman, N. Blumberg, 1996, Vox sanguinis.

The power of primers

S. Dzik, 1998, Transfusion.

Nonmalignant diagnoses in patients. Case 1. Mediastinal lymphadenopathy associated with congestive heart failure.

S. Dzik, Ann H. Partridge, Selim Nasser, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sustained phenotypic correction of murine hemophilia A by in vivo gene therapy

S. Dzik, 1999 .

Radio frequency identification for prevention of bedside errors

S. Dzik, Sunny Dzik, 2007, Transfusion.

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

J. Freedman, M. Reid, S. Dzik, 1996 .

Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease

S. Dzik, 2000 .

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis

S. Dzik, 2000 .